Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2025 07:30 ET | Source: Uvax Bio

Uvax Bio Appoints Kevin O’Neill as Interim Chief Executive Officer

NEWARK, Del., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Uvax Bio, LLC, (“Uvax” or “the Company”) a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and...
April 26, 2023 07:30 ET | Source: Uvax Bio

Uvax Bio Announces Publication of Results from Preclinical Studies of HIV Vaccine Candidates

Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategiesPhase 1 clinical trial sponsored by National Institutes of Health expected to...